Karyopharm Therapeutics | KPTI - Market Capitalization


Karyopharm Therapeutics reported $210.6M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Abbott USD 158.05B 20.36B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 317.37B 20.27B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Xencor USD 1.19B 301M Jun/2026